Aortic Aneurysm
Aortic Aneurysm market is segmented by players, region (country), by Type and by Application. Pla ... Read More
Global Anti-nuclear Antibody (ANA) Testing Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Indirect Immunofluorescence
1.2.3 Enzyme-linked Immunosorbent Assay (ELISA)
1.2.4 Other
1.3 Market by Application
1.3.1 Global Anti-nuclear Antibody (ANA) Testing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-nuclear Antibody (ANA) Testing Market Perspective (2017-2028)
2.2 Anti-nuclear Antibody (ANA) Testing Growth Trends by Region
2.2.1 Anti-nuclear Antibody (ANA) Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anti-nuclear Antibody (ANA) Testing Historic Market Size by Region (2017-2022)
2.2.3 Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Region (2023-2028)
2.3 Anti-nuclear Antibody (ANA) Testing Market Dynamics
2.3.1 Anti-nuclear Antibody (ANA) Testing Industry Trends
2.3.2 Anti-nuclear Antibody (ANA) Testing Market Drivers
2.3.3 Anti-nuclear Antibody (ANA) Testing Market Challenges
2.3.4 Anti-nuclear Antibody (ANA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-nuclear Antibody (ANA) Testing Players by Revenue
3.1.1 Global Top Anti-nuclear Antibody (ANA) Testing Players by Revenue (2017-2022)
3.1.2 Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Players (2017-2022)
3.2 Global Anti-nuclear Antibody (ANA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-nuclear Antibody (ANA) Testing Revenue
3.4 Global Anti-nuclear Antibody (ANA) Testing Market Concentration Ratio
3.4.1 Global Anti-nuclear Antibody (ANA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-nuclear Antibody (ANA) Testing Revenue in 2021
3.5 Anti-nuclear Antibody (ANA) Testing Key Players Head office and Area Served
3.6 Key Players Anti-nuclear Antibody (ANA) Testing Product Solution and Service
3.7 Date of Enter into Anti-nuclear Antibody (ANA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-nuclear Antibody (ANA) Testing Breakdown Data by Type
4.1 Global Anti-nuclear Antibody (ANA) Testing Historic Market Size by Type (2017-2022)
4.2 Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Type (2023-2028)
5 Anti-nuclear Antibody (ANA) Testing Breakdown Data by Application
5.1 Global Anti-nuclear Antibody (ANA) Testing Historic Market Size by Application (2017-2022)
5.2 Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Anti-nuclear Antibody (ANA) Testing Market Size (2017-2028)
6.2 North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022)
6.3 North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Anti-nuclear Antibody (ANA) Testing Market Size (2017-2028)
7.2 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022)
7.3 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size (2017-2028)
8.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022)
8.3 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Anti-nuclear Antibody (ANA) Testing Market Size (2017-2028)
9.2 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022)
9.3 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size (2017-2028)
10.2 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022)
10.3 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Detail
11.1.2 Abcam Business Overview
11.1.3 Abcam Anti-nuclear Antibody (ANA) Testing Introduction
11.1.4 Abcam Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
11.1.5 Abcam Recent Development
11.2 Antibodies
11.2.1 Antibodies Company Detail
11.2.2 Antibodies Business Overview
11.2.3 Antibodies Anti-nuclear Antibody (ANA) Testing Introduction
11.2.4 Antibodies Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
11.2.5 Antibodies Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Alere
11.4.1 Alere Company Detail
11.4.2 Alere Business Overview
11.4.3 Alere Anti-nuclear Antibody (ANA) Testing Introduction
11.4.4 Alere Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
11.4.5 Alere Recent Development
11.5 Erba Diagnostics
11.5.1 Erba Diagnostics Company Detail
11.5.2 Erba Diagnostics Business Overview
11.5.3 Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Introduction
11.5.4 Erba Diagnostics Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
11.5.5 Erba Diagnostics Recent Development
11.6 MBL International
11.6.1 MBL International Company Detail
11.6.2 MBL International Business Overview
11.6.3 MBL International Anti-nuclear Antibody (ANA) Testing Introduction
11.6.4 MBL International Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
11.6.5 MBL International Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Anti-nuclear Antibody (ANA) Testing Introduction
11.7.4 Merck Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
11.7.5 Merck Recent Development
11.8 Indur Services
11.8.1 Indur Services Company Detail
11.8.2 Indur Services Business Overview
11.8.3 Indur Services Anti-nuclear Antibody (ANA) Testing Introduction
11.8.4 Indur Services Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
11.8.5 Indur Services Recent Development
11.9 Trinity Biotech
11.9.1 Trinity Biotech Company Detail
11.9.2 Trinity Biotech Business Overview
11.9.3 Trinity Biotech Anti-nuclear Antibody (ANA) Testing Introduction
11.9.4 Trinity Biotech Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
11.9.5 Trinity Biotech Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Detail
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Introduction
11.10.4 Thermo Fisher Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
11.10.5 Thermo Fisher Scientific Recent Development
11.11 Zeus Scientific
11.11.1 Zeus Scientific Company Detail
11.11.2 Zeus Scientific Business Overview
11.11.3 Zeus Scientific Anti-nuclear Antibody (ANA) Testing Introduction
11.11.4 Zeus Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
11.11.5 Zeus Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Indirect Immunofluorescence
Table 3. Key Players of Enzyme-linked Immunosorbent Assay (ELISA)
Table 4. Key Players of Other
Table 5. Global Anti-nuclear Antibody (ANA) Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Anti-nuclear Antibody (ANA) Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Anti-nuclear Antibody (ANA) Testing Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Anti-nuclear Antibody (ANA) Testing Market Share by Region (2017-2022)
Table 9. Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Anti-nuclear Antibody (ANA) Testing Market Share by Region (2023-2028)
Table 11. Anti-nuclear Antibody (ANA) Testing Market Trends
Table 12. Anti-nuclear Antibody (ANA) Testing Market Drivers
Table 13. Anti-nuclear Antibody (ANA) Testing Market Challenges
Table 14. Anti-nuclear Antibody (ANA) Testing Market Restraints
Table 15. Global Anti-nuclear Antibody (ANA) Testing Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Anti-nuclear Antibody (ANA) Testing Market Share by Players (2017-2022)
Table 17. Global Top Anti-nuclear Antibody (ANA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-nuclear Antibody (ANA) Testing as of 2021)
Table 18. Ranking of Global Top Anti-nuclear Antibody (ANA) Testing Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Anti-nuclear Antibody (ANA) Testing Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Anti-nuclear Antibody (ANA) Testing Product Solution and Service
Table 22. Date of Enter into Anti-nuclear Antibody (ANA) Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type (2017-2022)
Table 26. Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type (2023-2028)
Table 28. Global Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Application (2017-2022)
Table 30. Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Application (2023-2028)
Table 32. North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 42. Abcam Company Detail
Table 43. Abcam Business Overview
Table 44. Abcam Anti-nuclear Antibody (ANA) Testing Product
Table 45. Abcam Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
Table 46. Abcam Recent Development
Table 47. Antibodies Company Detail
Table 48. Antibodies Business Overview
Table 49. Antibodies Anti-nuclear Antibody (ANA) Testing Product
Table 50. Antibodies Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
Table 51. Antibodies Recent Development
Table 52. Bio-Rad Laboratories Company Detail
Table 53. Bio-Rad Laboratories Business Overview
Table 54. Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Product
Table 55. Bio-Rad Laboratories Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
Table 56. Bio-Rad Laboratories Recent Development
Table 57. Alere Company Detail
Table 58. Alere Business Overview
Table 59. Alere Anti-nuclear Antibody (ANA) Testing Product
Table 60. Alere Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
Table 61. Alere Recent Development
Table 62. Erba Diagnostics Company Detail
Table 63. Erba Diagnostics Business Overview
Table 64. Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Product
Table 65. Erba Diagnostics Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
Table 66. Erba Diagnostics Recent Development
Table 67. MBL International Company Detail
Table 68. MBL International Business Overview
Table 69. MBL International Anti-nuclear Antibody (ANA) Testing Product
Table 70. MBL International Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
Table 71. MBL International Recent Development
Table 72. Merck Company Detail
Table 73. Merck Business Overview
Table 74. Merck Anti-nuclear Antibody (ANA) Testing Product
Table 75. Merck Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
Table 76. Merck Recent Development
Table 77. Indur Services Company Detail
Table 78. Indur Services Business Overview
Table 79. Indur Services Anti-nuclear Antibody (ANA) Testing Product
Table 80. Indur Services Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
Table 81. Indur Services Recent Development
Table 82. Trinity Biotech Company Detail
Table 83. Trinity Biotech Business Overview
Table 84. Trinity Biotech Anti-nuclear Antibody (ANA) Testing Product
Table 85. Trinity Biotech Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
Table 86. Trinity Biotech Recent Development
Table 87. Thermo Fisher Scientific Company Detail
Table 88. Thermo Fisher Scientific Business Overview
Table 89. Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Product
Table 90. Thermo Fisher Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
Table 91. Thermo Fisher Scientific Recent Development
Table 92. Zeus Scientific Company Detail
Table 93. Zeus Scientific Business Overview
Table 94. Zeus Scientific Anti-nuclear Antibody (ANA) TestingProduct
Table 95. Zeus Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million)
Table 96. Zeus Scientific Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-nuclear Antibody (ANA) Testing Market Share by Type: 2021 VS 2028
Figure 2. Indirect Immunofluorescence Features
Figure 3. Enzyme-linked Immunosorbent Assay (ELISA) Features
Figure 4. Other Features
Figure 5. Global Anti-nuclear Antibody (ANA) Testing Market Share by Application in 2021 & 2028
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Anti-nuclear Antibody (ANA) Testing Report Years Considered
Figure 10. Global Anti-nuclear Antibody (ANA) Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Anti-nuclear Antibody (ANA) Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Anti-nuclear Antibody (ANA) Testing Market Share by Region: 2021 VS 2028
Figure 13. Global Anti-nuclear Antibody (ANA) Testing Market Share by Players in 2021
Figure 14. Global Top Anti-nuclear Antibody (ANA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-nuclear Antibody (ANA) Testing as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Anti-nuclear Antibody (ANA) Testing Revenue in 2021
Figure 16. North America Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Anti-nuclear Antibody (ANA) Testing Market Share by Country (2017-2028)
Figure 18. United States Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Anti-nuclear Antibody (ANA) Testing Market Share by Country (2017-2028)
Figure 22. Germany Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Share by Region (2017-2028)
Figure 30. China Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Anti-nuclear Antibody (ANA) Testing Market Share by Country (2017-2028)
Figure 38. Mexico Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Share by Country (2017-2028)
Figure 42. Turkey Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Abcam Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
Figure 45. Antibodies Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
Figure 46. Bio-Rad Laboratories Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
Figure 47. Alere Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
Figure 48. Erba Diagnostics Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
Figure 49. MBL International Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
Figure 50. Merck Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
Figure 51. Indur Services Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
Figure 52. Trinity Biotech Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
Figure 54. Zeus Scientific Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abcam Antibodies Bio-Rad Laboratories Alere Erba Diagnostics MBL International Merck Indur Services Trinity Biotech Thermo Fisher Scientific Zeus Scientific